OPK News and Press, Opko Health Inc. From 08/04/23

2023-08-04 01:00:22 ET Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q2 2023 Earnings Call Aug 03, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q2 2023 Earnings Call Transcript

2023-08-04 00:17:04 ET OPKO Health, Inc. (OPK) Q2 2023 Earnings Conference Call August 3, 2023 16:30 ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman & Chief Executive Officer Elias Zerhouni - President & Vice Chairm...

2023-08-03 16:10:44 ET OPKO Health press release ( NASDAQ: OPK ): Q2 GAAP EPS of -$0.03 beats by $0.04 . Revenue of $265.4M (-14.4% Y/Y) beats by $63.43M . For further details see: OPKO Health GAAP EPS of -$0.03 beats by $0.04, revenue of $265.4M beats by...

MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2023. Second quarter business highlights included the following: U.S. FDA approved NGENLA™ for pediatric ...

2023-07-31 14:19:19 ET Summary OPKO Health stock has bounced back since February but remains down over 11% since last year. OPK stock's rally in recent months has been supported by strong buying volume and positive earnings revisions. The company's collaboration with Merck and...

MIAMI, July 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2023 after the close of the U.S. financial markets on Thursday, August 3, 2023. OPKO’s senior management will provide a b...

Thinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences? PR Newswire NEW YORK , July 14, 2023 InvestorsObserver issues critical PriceWatch Alerts for MNMD, OPK, GRR, HYZN, and DRUG. ...

2023-06-30 09:15:22 ET Summary Ngenla, a long-acting medicine for treating children with growth hormone deficiency, has been approved by the FDA for use in the United States, adding to its presence in over 40 countries. Pfizer Inc. and Opko Health have been jointly developing and ...

2023-06-29 15:51:58 ET Shares of Opko Health (NASDAQ: OPK) were up more than 11% around 2:30 p.m. ET on Thursday. The healthcare company announced after the markets closed on Wednesday that a treatment for pediatric growth hormone deficiency that it was developing with Pfizer ...

2023-06-28 10:09:16 ET Gainers: Minerva Neurosciences ( NERV ) +51% . Regional Health Properties ( RHE ) +12% . Genfit ( GNFT ) +11% . RenovoRx ( RNXT ) +11% . OPKO Health ( OPK ) +5% . Losers: Cognition Therapeutics ( C...